Nanopore Diagnostics
St. Louis, US · Founded 2011 · Missouri LLC
Founders & leadership
TC
Thomas CohenExecutive
CB
Christoph BauschNamed on SEC filing
Board
CB
Charles BoltenBoard director
Reported raises · per SEC filings
Form D private placements$585K disclosed across 1 round · 2015
▶$585KraisedJan 2016 · 10 investors · BiotechnologyRule 506(b)
▶$585KraisedJan 2016 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christoph BauschDirector
- Thomas CohenExecutive Officer
- Charles BoltenDirector
- Offering amount
- $1M
- Amount sold
- $585K
- Minimum investment
- $25K
- First sale
- Oct 2015
- Incorporated
- Limited Liability Company, Missouri, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Nanopore Diagnostics raised?
- Nanopore Diagnostics has disclosed $585K raised across 1 round.
- Where is Nanopore Diagnostics headquartered?
- Nanopore Diagnostics is headquartered in St. Louis, US.